Ramipril and the development of diabetes

JAMA

Volumn 286, Issue 15, 2001, Pages 1882-1885

  Yusuf, Salim ^a   Gerstein, Hertzel ^a   Hoogwerf, Byron ^b   Pogue, Janice ^a   Bosch, Jackie ^a   Wolffenbuttel, Bruce H R ^c   Zinman, Bernard ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; PLACEBO; RAMIPRIL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035904369     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.15.1882     Document Type: Article

References (19)

1. Economic consequences of diabetes mellitus in the US in 1997
2. Global burden of diabetes, 1995-2025
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
7. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus
8. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance
9. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
10. Effects of ramipril and vitamin E on hematological markers of fibrinolysis, coagulation and endothelial function: Results of the MORE-HOPE study
11. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension
12. Insulin and the renin-angiotensin-aldosterone system
13. Angiotensin II and the endocrine pancreas
14. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats
15. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus
16. ACE inhibition and glucose transport in insulin resistant muscle: Roles of bradykinin and nitric oxide
17. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non-diabetic hypertensive patients
18. Vascular reactivity
19. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension